EC Number |
Inhibitors |
Structure |
---|
2.3.2.12 | 1-ethyl-4-[(2-phenylthiazol-4-yl)methyl]piperazine |
i.e. ZINC19595411 |
|
2.3.2.12 | 1-[(2-methylthiazol-4-yl)methyl]-4-[(2-phenylthiazol-4-yl)methyl]piperazine |
i.e. ZINC22812775 |
|
2.3.2.12 | 40S subunits of ribosomes |
inhibition proportional to the 40S-subunit-concentration |
|
2.3.2.12 | Amicetin |
complete inhibition with AcPhe-tRNA as donor, with polylysyl-tRNA as donor less active |
|
2.3.2.12 | Amicetin |
less potent than oxamicetin |
|
2.3.2.12 | Amicetin |
- |
|
2.3.2.12 | ampicillin |
strain 18sH Con-, 60 microg/ml, 50 percent inhibition; strain 18s SAI-, 3 microg/ml, 50 percent inhibition |
|
2.3.2.12 | anisomycin |
inhibition of formation of AcPhe-puromycin catalyzed by rabbit reticulocyte ribosomes |
|
2.3.2.12 | anisomycin |
- |
|
2.3.2.12 | arginine attenuator peptide |
the wild type arginine attenuator peptide (AAP) inhibits peptidyl transferase center (PTC) function. AAP containing the D12N mutation, which eliminates Arg-induced ribosome stalling, also eliminates Arg's effect on PTC function |
|